SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-16-016103
Filing Date
2016-04-12
Accepted
2016-04-12 16:15:43
Documents
5
Period of Report
2016-05-26
Effectiveness Date
2016-04-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A vktx-def14a_20160526.htm DEF 14A 850733
2 GRAPHIC guotakxmgj3p000004.jpg GRAPHIC 80185
3 GRAPHIC guotakxmgj3p000001.jpg GRAPHIC 3305
4 GRAPHIC guotakxmgj3p000002.jpg GRAPHIC 3305
5 GRAPHIC guotakxmgj3p000003.jpg GRAPHIC 44364
  Complete submission text file 0001564590-16-016103.txt   1033006
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37355 | Film No.: 161567386
SIC: 2834 Pharmaceutical Preparations